Epsilon Healthcare Ltd Total Liabilities

Latest as of June 2026: AU$15.59 Million AUD ≈ $11.03 Million USD

Epsilon Healthcare Ltd total liabilities. Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has total liabilities worth AU$15.59 Million AUD (≈ $11.03 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Epsilon Healthcare Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Epsilon Healthcare Ltd (2016–2025)

Total liabilities of Epsilon Healthcare Ltd from 2016 to 2025. This chart illustrates how Epsilon Healthcare Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore EPN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Epsilon Healthcare Ltd Competitors by Total Liabilities

The table below lists competitors of Epsilon Healthcare Ltd ranked by their total liabilities.

Company Country Total Liabilities
Merino & Co. Ltd
AU:MNC
Australia AU$4.50 Million
Tambourah Metals Ltd
AU:TMB
Australia AU$359.91K
PEPTONIC MEDICAL
F:28L
Germany €11.59 Million
Ajooni Biotech Limited
NSE:AJOONI
India Rs291.74 Million
ConnectM Technology Solutions, Inc.
NASDAQ:CNTM
USA $40.77 Million
TOP Ships Inc.
NYSE MKT:TOPS
USA $244.42 Million
Form Bio Co. Ltd.
KQ:377220
Korea ₩39.64 Billion
Cahaya Bintang Medan Tbk Pt
JK:CBMF
Indonesia Rp117.80 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Epsilon Healthcare Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see EPN total asset value.

Liquidity & Leverage Metrics

Epsilon Healthcare Ltd Total Liabilities Ratios Explained

Epsilon Healthcare Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.82 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.02 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.80 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epsilon Healthcare Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual total liabilities of Epsilon Healthcare Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$15.95 Million
≈ $11.29 Million
+37.94%
2024-12-31 AU$11.57 Million
≈ $8.18 Million
+68.29%
2023-12-31 AU$6.87 Million
≈ $4.86 Million
-38.80%
2022-12-31 AU$11.23 Million
≈ $7.95 Million
+2.27%
2021-12-31 AU$10.98 Million
≈ $7.77 Million
-8.06%
2020-12-31 AU$11.94 Million
≈ $8.45 Million
+117.47%
2019-12-31 AU$5.49 Million
≈ $3.89 Million
+17.90%
2018-12-31 AU$4.66 Million
≈ $3.30 Million
+691.15%
2017-12-31 AU$588.83K
≈ $416.63K
+403.30%
2016-12-31 AU$116.99K
≈ $82.78K
--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.51 Million
AU$7.78 Million AUD
Market Cap Rank
#28291 Global
#1450 in Australia
Share Price
AU$0.02
Change (1 day)
-13.04%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$1.08
About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more